Clinical Study of Domestic Polysaccharide Superparamagnetic Iron Oxide Nanoparticle Injection for Coronary Artery Contrast-enhanced Magnetic Resonance Contrast-enhanced Angiography
Latest Information Update: 17 Jan 2023
At a glance
- Drugs Domestic polysaccharide superparamagnetic iron oxide nanoparticle-Chia Tai Tianqing Pharmaceutical Group (Primary)
- Indications Coronary disorders
- Focus Adverse reactions; Diagnostic use
- 11 Jan 2023 Status changed from recruiting to completed.
- 06 Aug 2022 Planned End Date changed from 1 Jul 2022 to 1 Jul 2023.
- 06 Aug 2022 Planned primary completion date changed from 31 Mar 2022 to 31 Mar 2023.